Piqhasso: Open Label, Non-Randomized, Multicenter Phase 1/2b Study Investigating Safety And Efficacy Of Pqr309 And Eribulin Combination In Patients (Pts) With Locally Advanced (La) Or Metastatic Her2 (-) And Triple-Negative Breast Cancer (Tnbc) (Study Pqr309-007)